NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)

This study has been completed.
Sponsor:
Collaborator:
American Society of Clinical Oncology
Information provided by:
Ludwig Institute for Cancer Research
ClinicalTrials.gov Identifier:
NCT00142454
First received: September 1, 2005
Last updated: September 20, 2007
Last verified: September 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Estimated Primary Completion Date: No date given